Fate of Nutrient-Derived Amino Acids, FONDAA (FONDAA)

March 2, 2018 updated by: Grith Højfeldt, Bispebjerg Hospital

Fate of Nutrient-Derived Amino Acids: Influence of Habituated Levels of Daily Dietary Protein Intake on Protein Utilization

12 elderly (65-70 years of age) male subjects will be included and complete a double blinded cross-over study. They will be habituated for 21 days to either low or high protein intake (below 0.8 g/kg or above 1.5 g/kg, respectively). Following a 45 day washout period they will switch to the alternate group. At the end of each habituation period, the investigators will measure the appearance of labelled amino acids from milk proteins.

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2400
        • Institute of Sports Medicine Copenhagen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 70 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Exclusion Criteria:

  • Hyperlipidemia
  • Hypertension

Inclusion Criteria:

  • Males age 65-70
  • Independently dwelling
  • Without any major health issues (blood pressure, cholesterol and lipid profile will be measured and evaluated by a physician)
  • Non-diabetic
  • No organ disease
  • No back pain
  • Not regularly take any prescription drugs or dietary supplements, which can influence muscle protein synthesis
  • Alcohol intake below 21 units pr. week
  • No known arthrosclerosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Meal serving at high dietary protein
Test the handling of meal-served protein when habituated to high dietary protein at an amount above 1.5 g protein/kg/day
Participants are habituated to a high level of dietary protein intake for 21 days.
To investigate impact of habituated protein level
Active Comparator: Meal serving at low dietary protein
Test the handling of meal-served protein when habituated to high dietary protein at an amount below 0.8 g protein/kg/day
To investigate impact of habituated protein level
Participants are habituated to a low level of dietary protein intake for 21 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abundance of milk protein-bound amino acid labels in blood protein.
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in liver-synthesized blood protein at 240 min.

Baseline to 240 min postprandial

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abundance of milk protein-bound amino acid labels in myofibrillar protein.
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in myofibrillar protein at 240 min.

Baseline to 240 min postprandial
Leg phenylalanine rate of disappearance and appearance, net balance.
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

From arterial and femoral venous blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments and concentrations as well as plasma flow will be measured.

Baseline to 240 min postprandial
First pass splanchnic extraction of dietary protein-derived labeled phenylalanine.
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

From hepatic venous blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments and concentrations as well as plasma flow will be measured. Knowing the amount of ingested protein and labeled phenylalanine we can calculate the first pass splanchnic amino acid extraction.

Baseline to 240 min postprandial
Whole body phenylalanine rate of disappearance and appearance, net balance.
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

From blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments will be measured.

Baseline to 240 min postprandial
The myofibrillar protein fractional synthesis rate
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

From muscle biopsies obtained at baseline, 60 and 240 min the abundance of phenylalanine tracer bound in the myofibrillar proteins will be measured and the fractional synthesis rate will be measured within the first from baseline to 60 min and 240 min as well as from 60-240 min postprandial.

Baseline to 240 min postprandial
Response of expression of proteins involved in muscle protein turnover
Time Frame: Baseline, 60 min and 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

From baseline to 60 and 240 min after intake of the standardized meal after 21 days of habituation to either a high or a low dietary protein intake expression of signalling proteins related to protein turnover in the muscle will be measured by use of western blotting.

Baseline, 60 min and 240 min postprandial
Urea production.
Time Frame: Baseline to 240 min postprandial

Related to the trials conducted after 21 days of habituation to either high or low protein in the diet:

From blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min urea tracer enrichments and concentrations will be measured. With this, and flow measurements, we can determine the rate of urea production.

Baseline to 240 min postprandial
Nitrogen and creatinine excreted in urine
Time Frame: 21 days post intervention, 240 min postprandial and 24 hours post the day 21 trial day

Related to the adaptation to the 21 day habituation period to either high or low protein in the diet as well as the response to the standardized trial meal:

Nitrogen and creatinine content is measured in urine is collected for the last 24 h of the 21 day habituation period, as well as during the 240 min trial day and the remaining 20 hours of the trial day.

21 days post intervention, 240 min postprandial and 24 hours post the day 21 trial day
Fecal microbiota composition
Time Frame: Change from pre-intervention to 21 days and 22 days (21 intervention days habituation and the standardized trial meal on day 21)

Related to the adaptation to the 21 day habituation period to either high or low protein in the diet as well as the response to the standardized trial meal:

The microbiota compositions, will be measured in fecal samples collected before the 21 day habituation period, after the 21 day habituation periode, as well as after the 240 min trial day

Change from pre-intervention to 21 days and 22 days (21 intervention days habituation and the standardized trial meal on day 21)
Adaptation of expression of proteins involved in muscle protein turnover
Time Frame: After 21 days of habituation to either a high or a low dietary protein intake.

Related to the adaptation to the 21 day habituation period to either high or low protein in the diet:

Biopsies taken following the two 21 day habituation period will, by use of western blotting, be analysed for expression of signalling proteins involved in muscle protein turnover.

After 21 days of habituation to either a high or a low dietary protein intake.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Grith Højfeldt, M.Sc., Bispebjerg Hospital
  • Principal Investigator: Lars Holm, Ph.D., Bispebjerg Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

February 8, 2018

Study Completion (Actual)

February 8, 2018

Study Registration Dates

First Submitted

October 22, 2015

First Submitted That Met QC Criteria

October 26, 2015

First Posted (Estimate)

October 27, 2015

Study Record Updates

Last Update Posted (Actual)

March 5, 2018

Last Update Submitted That Met QC Criteria

March 2, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • BBH122

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary Protein

Clinical Trials on Meal serving at high dietary protein

3
Subscribe